Document:

evok-ex41_6.htm

Exhibit 4.1

 

FORM OF

 

AMENDMENT TO COMMON STOCK PURCHASE WARRANT

 

 

This Amendment to Common Stock Purchase Warrant (this “Amendment”), dated as of March 29, 2018, is being entered into by and between Evoke Pharma, Inc., a Delaware corporation (the “Company”), and _____________________ (the “Holder”).  

 

WHEREAS, the Holder is the record and beneficial owner of certain warrants (the “Existing Warrants”) to purchase shares of the Company’s common stock, par value $0.0001 per share, set forth on Exhibit A hereto; and 

 

WHEREAS, the Company and the Holder have agreed to amend the Existing Warrants in the manner provided in this Amendment (the Existing Warrants, as so amended, the “Warrants”).

 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, it is hereby agreed as follows:

 

Section 1.Amendment to Warrant.  The Existing Warrants are amended by replacing the fourth sentence of Section 3(d) of each Existing Warrant in its entirety with the following sentence:

“Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder’s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction, purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction; provided, however, if the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of Directors, Holder shall only be entitled to receive from the Company or any Successor Entity, as of the date of consummation of such Fundamental Transaction, the same type or form of consideration (and in the same proportion), at the Black Scholes Value (as defined below) of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction.”

Section 2.Most Favored Nations. The Company covenants and agrees that it has not entered into an amendment agreement with any other holder of Existing Warrants (each, an “Other Holder”) for any material amendments, modifications or exchanges to the terms of such Existing Warrants (or settlement or exchange of such Existing Warrants for other material consideration) (each, a “More Favorable Agreement”), that is more favorable to such Other Holder than those of the Holder pursuant to this Agreement.  If the Company enters into a More Favorable Agreement with terms that are materially 

different from this Agreement (“material” shall be in the reasonable determination of the Holder), then (i) the Company shall provide written notice thereof to the Holder promptly following the occurrence thereof and (ii) the terms and conditions of this Agreement that shall be, without any further action by the Holder or the Company, automatically and retroactively to the date hereof, amended and modified in an economically and legally equivalent manner such that the Holder shall receive the benefit of such more favorable material terms and/or conditions (as the case may be) set forth in such More Favorable Agreement, provided that, upon written notice to the Company within five business days of such Company’s written notice, the Holder may elect not to accept the benefit of any such amended or modified material term or condition, in which event the material terms or conditions contained in this Agreement shall continue to apply to the Holder as it was in effect immediately prior to such amendment or modification as if such amendment or modification never occurred with respect to the Holder.  The provisions of this paragraph shall apply similarly and equally to each More Favorable Agreement and shall be effective whether or not the Holder holds Existing Warrants at such time.  The Company will notify the Holder any time it enters into any agreement with any Other Holder relating to the Existing Warrants and, at the request of the Holder, provide the Holder with such agreement for its review.

Section 3.Miscellaneous.

(A)No Other Amendment.  Except for the matters set forth in this Amendment, all other terms of the Warrants shall remain unchanged and in full force and effect.

(B)Governing Law.  This Amendment shall be governed by and construed in accordance with, and all questions concerning the construction, validity, interpretation and performance of this Amendment shall be governed by, the laws of the State of New York, except for its conflicts of law provisions.

(C)Counterparts.  This Amendment may be executed in the original or by facsimile in two or more counterparts, each of which shall be deemed an original and all of which, taken together, shall constitute but one and the same instrument.

[Remainder of Page Intentionally Left Blank; Signature Page Follows]

 

 

The parties hereto have executed this Amendment as of the date first written above.

 

EVOKE PHARMA, INC.

 

 

 

By:

	
 
	
Name:
	

	
 
	
Title:
	

 

 

[HOLDER]

 

 

 

By:

	
 
	
Name:
	

	
 
	
Title:Blueprint

Exhibit 10.1

 

 

SECOND AMENDMENT TO

REAL PROPERTY PURCHASE AND SALE AGREEMENT

 

This
Second Amendment to Real Property Purchase and Sale Agreement (the
“Second
Amendment”) is made and entered into as of the 29th
day of March, 2018, by and between The State Media Company, a South
Carolina corporation (“Seller”), and Voltari
Real Estate Holding LLC, a Delaware limited liability company
(“Buyer”).

 

RECITALS

 

 

A.           

Seller and Buyer
entered into a Real Property Purchase and Sale Agreement, dated as
of January 19, 2018, as amended by that First Amendment to Real
Property Purchase and Sale Agreement, dated as of February 26, 2018
(as amended, the “Purchase
Agreement”).

 

B.           

Seller and Buyer
desire to amend the Purchase Agreement to extend each of the Review
Period and the Closing Date (as each is defined therein) for an
additional seven (7) days.

 

NOW, THEREFORE, in consideration of the
mutual promises set forth herein and other good and valuable
consideration, the receipt and sufficiency of which is hereby
acknowledged, the parties agree as follows:

 

1. Recitals. The foregoing recitals are
true and correct and are incorporated herein by this
reference.

 

2. Extension of Review Period. Section
8.2.1 of the Purchase Agreement is hereby deleted in its entirety
and the following is substituted in place thereof:

 

“8.2.1                       

Review Period. Buyer shall have
until April 6, 2018 (the “Review Period”) to accept and
approve, in Buyer’s sole discretion, the Property and the
results of any and all Studies with respect to the Property as
Buyer may elect to make or obtain, including without limitation,
Studies regarding or concerning zoning, building codes, design
review standards, and other governmental regulations;
architectural, mechanical, building systems, and structural
inspections; engineering tests; availability of water and
utilities; soils, seismic and geologic condition; physical and
environmental condition; entitlements; ability to develop, improve
or remodel the Property; marketing and economic studies; and
contracts and documents concerning the Property. Buyer, in its sole
and exclusive discretion, may terminate this Agreement, for any or
no reason, whatsoever, at any time, prior to 5:00 p.m. Eastern Time
on April 6, 2018 (the “Review
Period Deadline”). Upon any such termination of this
Agreement pursuant to Buyer’s rights under this Section
8.2.1, the Initial Deposit (and any accrued interest thereon) shall
be promptly returned to Buyer, and Buyer and Seller shall have no
further rights and obligations hereunder except those which
expressly survive termination of this Agreement. The failure of
Buyer to terminate this Agreement in writing prior to the Review
Period Deadline shall irrevocably be deemed to constitute
Buyer’s (a) unconditional approval of its Studies and the
condition of the Property, (b) election to close its acquisition of
the Property subject to satisfaction of the other conditions set
forth in this Section 8.2, and (c) agreement that the Deposit is
nonrefundable to Buyer except as otherwise noted in Section 2.2.2
hereof. The cost of all such inspections, tests and Studies shall
be borne exclusively by Buyer.”

 

 

1

 

 

3. Extension of Closing. Section 3.1 of the
Purchase Agreement is hereby deleted in its entirety and the
following is substituted in place thereof:

 

“3.1            

Place and Date. The purchase
and sale of the Property shall be completed in accordance with
Article 9 hereof (the “Closing”). The Closing shall occur
by mail through an escrow (the “Escrow”) with First
American Title (the “Settlement Agent”), whose address
is Six Concourse Parkway, Suite 2150, Atlanta, GA 30328, Attn:
Leslie A. Hudson, or at such other place as Seller and Buyer agree
in writing, on the basis of a “deed and money” escrow
closing. The Escrow shall be deemed open on the date Buyer delivers
the Initial Deposit to the Settlement Agent. Subject to the
conditions precedent described in Article 8 hereof, the Closing
shall occur not later than April 23, 2018, unless extended by
Seller and Buyer in writing (the date on which the Closing occurs
being hereinafter sometimes referred to as the “Closing Date”). In the event there
exists a failed condition to Buyer’s or Seller’s
obligation and Buyer and Seller do not agree to extend the Closing
Date, or such failed condition exists after expiration of any such
extension, then the party for whose benefit such condition exists
may waive the condition or terminate this Agreement by written
notice to the other party and to the Settlement Agent. The Escrow
shall be considered closed when the Deed is recorded in the
Official Records of Richland County, South Carolina
(“Official
Records”).”

 

4. Miscellaneous.

 

A. Each of Seller and
Buyer represents and warrants to the other that it has not
transferred or assigned its interests in, to and under the Purchase
Agreement and has full power and authority to enter into this
Second Amendment and that the Purchase Agreement, as amended by
this Second Amendment, shall be binding on Seller and Buyer,
respectively.

 

B. Terms not
specifically defined within this Second Amendment shall have the
meaning set forth in the Purchase Agreement.

 

C. Except as herein
specifically modified and amended, the Purchase Agreement shall
remain in full force and effect. From and after the date hereof,
the term "this Agreement" shall be deemed to refer to the Purchase
Agreement, as amended by this Second Amendment. If and to the
extent that any of the provisions of this Second Amendment conflict
or are otherwise inconsistent with any provisions of the Purchase
Agreement, the provisions of this Second Amendment shall
prevail.

 

D. This Second
Amendment shall be governed in all respects by the laws of the
State of South Carolina without regard to principles of conflict of
law.

 

E. This Second
Amendment may be executed in counterparts, and electronic
transmittal of the executed Second Amendment by each party shall be
sufficient to create a valid and binding agreement.

 

F. This Second
Amendment shall be binding upon the parties hereto and their
respective heirs, successors and assigns.

 

[REMAINDER
OF PAGE INTENTIONALLY BLANK - SIGNATURE PAGE FOLLOWS]

 

 

2

 

 

IN WITNESS WHEREOF, Seller and Buyer
have executed this Second Amendment on the date first above
written.

 

	

SELLER:

 

THE STATE MEDIA COMPANY,

a South
Carolina corporation

 

By:
/s/ R. Elaine
Lintecum

Name:
R. Elaine Lintecum

Title:
Vice President, Asst. Secretary and Treasurer

	
 

	

BUYER:

 

VOLTARI REAL ESTATE HOLDING LLC,

a
Delaware limited liability company

 

By:
/s/ Peter
Kaouris

Name:
Peter Kaouris

Its:
Chief Accounting Officer

	
 

	
 

	
 

 

 

 

 

 

 

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00281-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00281-of-00352.parquet"}]]